CNE100001FF1
CNE100001FF1
BOYA BIOLOGY
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 7.5B EUR | 7.18B EUR | 9.36B EUR | 11.4B EUR |
Enterprise Value | 4.75B EUR | 6.48B EUR | 8.61B EUR | 10.89B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 11.45x | -- | -- | -- |
Price to Sales | 4.43x | 5.84x | 6.79x | 7.15x |
Price to Book | 1.01x | 0.96x | 1.25x | 1.53x |
EV/Revenue | 2.81x | 5.27x | 6.25x | 6.84x |
EV/EBITDA | 23.91x | 82.01x | 43.89x | 35.03x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -12.12% | -7.06% | -5.5% | -3.17% |